Mindfulness rewires reward pathways in cannabis addiction

This groundbreaking study examined whether mindfulness-based interventions (MBIs) could help restore normal brain reward function in people with moderate-to-severe cannabis use disorder (CUD). Researchers used brain imaging (fMRI) to measure how 49 participants' brains responded to monetary rewards before and after a 2-week intervention period. The study compared three groups: those who received mindfulness training, those who participated in a closely-matched relaxation control, and those who received no intervention. This rigorous design allowed researchers to isolate the specific effects of mindfulness rather than general benefits from any calming activity.

The results revealed that mindfulness training produced distinct changes in brain activity compared to the other conditions. After mindfulness training, participants showed decreased activity in the cerebellum when anticipating money and decreased activity in reward-related regions when receiving monetary wins—changes that suggest a normalization of overactive reward processing common in CUD. Interestingly, the active control group (relaxation) showed a different pattern of brain changes, with increased activity in several regions during reward processing. The no-intervention group also showed distinct changes, indicating that both active treatments produce measurable effects on brain function, though through different mechanisms.

While the study found no significant differences when examining specific reward regions (ventral striatum, orbitofrontal cortex, etc.) in isolation, the whole-brain analysis revealed important patterns. These findings suggest that mindfulness training may help rebalance disrupted reward circuits in cannabis users—a promising non-pharmacological approach for treating cannabis use disorder by literally reshaping how the brain processes motivation and reward. However, the small sample size and short intervention period mean these results are preliminary and require confirmation in larger, longer-term studies before clinical implementation."